VENLO, The Netherlands / GERMANTOWN, Md., November 20, 2007 - QIAGEN today announced that its newly released hepatitis B virus (HBV) assay kit is in compliance with Health Canada's medical device requirements. The artus HBV LC PCR Kit, which monitors the viral load of HBV infected patients, is now available to doctors in Canada to help them determine the success of a treatment.